A Study to Evaluate the Effectiveness and Patient-Reported Outcome of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in China
Clinical trial NCT03236870 · COMPLETED
Trial details
- NCT number
- NCT03236870
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-09-08
- Primary completion
- 2020-08-25
- Enrollment
- 181
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.